Yangyin Huowei mixture alleviates chronic atrophic gastritis by inhibiting the IL-10/JAK1/STAT3 pathway

Table 4 Effects of YYHWM on protein expression levels of IL-10, JAK1, and STAT3 in rat gastric tissues (mean ± SD)

Group	IL-10/GADPH	JAK1/GADPH	STAT3/GADPH
Blank control	0.47 ± 0.10e	0.49 ± 0.05e,f	0.24 ± 0.05e,f
Model	1.11 ± 0.09d,f	0.99 ± 0.07d,f	1.04 ± 0.14c,d
Low-dose YYHWM	0.76 ± 0.11a,e	0.75 ± 0.07d,e,f	1.07 ± 0.11d,f
Medium-dose YYHWM	0.41 ± 0.12c,e	0.69 ± 0.07b,d,f	0.50 ± 0.13e
High-dose YYHWM	0.19 ± 0.07a,e,f	0.51 ± 0.05d	0.55 ± 0.09a,e
Vitacoenzyme	0.71 ± 0.08e	0.38 ± 0.07d	0.70 ± 0.04b,d
F value	33.39	35.70	31.08
P value	< 0.01	< 0.01	< 0.01

^aP < 0.05 compared with blank control group.

^bP < 0.05 compared with model group.

^cP < 0.05 compared with model group.

^dP < 0.01 compared with blank control group.

^eP < 0.01 compared with model group.

^fP < 0.01 compared with vitacoenzyme group.

YYHWM: Yangyin Huowei mixture.